ストックスクリーナーアプリを入手
318.41
0.05%
0.18
アフターアワーズ：
318.31
-0.10
-0.03%
Penumbra Inc (PEN) 最新ニュース
Penumbra enrolls first patient in distal acute stroke thrombectomy study - MassDevice
First Patient Enrolled in Penumbra's FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke - BioSpace
Penumbra (PEN) Launches FORWARD Study to Assess Stroke Treatment Methods - GuruFocus
Penumbra initiates study on stroke treatment for distal occlusions By Investing.com - Investing.com Canada
GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT - GlobeNewswire Inc.
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 14.40% Potential Upside - DirectorsTalk Interviews
PENPenumbra Inc Volatility & Greeks - Finviz
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Penumbra Inc. (PEN) Holds Steady Near Resistance Level as Trading Volume Remains ModerateDollar Neutral Pair - dars.gov.et
Price to earnings forward of Penumbra, Inc. – DUS:0P8 - TradingView
Penumbra Receives CE Mark for Reperfusion Catheters - dicardiology.com
Penumbra secures European CE mark for Red 72 Silver Label technologies - NeuroNews International
Penumbra, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.033333 Sh - TradingView
REAL Aspiration Catheter from Penumbra Inc.large-vessel stroke workhorse for interventional suite - AD HOC NEWS
PEN Forecast — Price Target — Prediction for 2027 - TradingView
Penumbra Update - TMX Newsfile
Price to book forward of Penumbra, Inc. – HAM:0P8 - TradingView
Enterprise value to EBITDA forward of Penumbra, Inc. – HAM:0P8 - TradingView
Penumbra, Inc. Actuals & Estimates (XETR:0P8) - TradingView
PEN Stock Price Prediction 2025-2026 | Penumbra Inc Forecast - 24/7 Wall St.
Price to sales forward of Penumbra, Inc. – HAM:0P8 - TradingView
Price to earnings forward of Penumbra, Inc. – HAM:0P8 - TradingView
0P8 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Penumbra, Inc. – NYSE:PEN - TradingView
Enterprise value to EBIT forward of Penumbra, Inc. – NYSE:PEN - TradingView
Form 8K Penumbra Inc For: 22 June By Investing.com - Investing.com South Africa
Penumbra, Inc. 8-K SEC Filing: Key Details, Business Address, NYSE Listing & Shareholder Vote Results - Minichart
Penumbra shareholders elect directors and approve executive pay at annual meeting - Investing.com Nigeria
Penumbra: Portfolio Expands With Approval To Treat Stroke; Acquisition by Boston on Track - Morningstar
Penumbra Expands Portfolio With Approval To Treat Stroke; Acquisition by Boston on Track - Morningstar
Penumbra (PEN) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary - Quartr
Penumbra StockAnalyst and earnings outlook as consensus settles - AD HOC NEWS
(PEN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Penumbra (NYSE:PEN) Medical Device Mid Caps Stay In Focus - Kalkine Media
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain? - TradingView
Why Penumbra Lightning Flash is drawing attention in stroke care - AD HOC NEWS
Penumbra wins CE mark for Thunderbolt clot removal tech - MedTech Dive
Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Penumbra Inc (PEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Penumbra (PEN) Proxy filing Summary - Quartr
Penumbra Inc (PEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Penumbra Inc (PEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Penumbra Inc (PEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Penumbra Inc (PEN) Institutional Confidence - TradingKey
Penumbra Inc (PEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Penumbra Inc (PEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Penumbra Inc (PEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ursa Fund Management, LLC's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation - Yahoo Finance
VIP Mid Cap Portfolio's Penumbra Inc(PEN) Holding History - GuruFocus
CE Mark Granted to Penumbra's CAVT Platform - dicardiology.com
Penumbra (PEN) Achieves CE Mark for Thunderbolt Technology - GuruFocus
Penumbra expands CAVT for stroke into Europe with Thunderbolt CE mark - NeuroNews International
Penumbra earns CE mark for Thunderbolt thrombectomy system - MassDevice
Penumbra’s Thunderbolt Computer-Assisted Vacuum Thrombectomy Earns CE Mark - Medical Product Outsourcing
Penumbra secures CE Mark for stroke treatment device in Europe By Investing.com - Investing.com South Africa
Penumbra Inc Expands Cavt For Stroke To Europe With CE Mark For Thunderbolt - TradingView
Penumbra secures CE Mark for stroke treatment device in Europe - Investing.com
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT - PR Newswire
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUN - GuruFocus
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Yahoo Finance UK
Penumbra CAVT Platform Receives FDA Clearance - dicardiology.com
FDA clears Penumbra’s Thunderbolt thrombectomy platform for stroke - Yahoo Finance
0.21%
1.23%
大文字化:
|
ボリューム (24 時間):